Locus specific human endogenous retroviruses reveal new lymphoma subtypes.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
08 Jun 2023
08 Jun 2023
Historique:
pubmed:
19
6
2023
medline:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
The heterogeneity of cancers are driven by diverse mechanisms underlying oncogenesis such as differential 'cell-of-origin' (COO) progenitors, mutagenesis, and viral infections. Classification of B-cell lymphomas have been defined by considering these characteristics. However, the expression and contribution of transposable elements (TEs) to B cell lymphoma oncogenesis or classification have been overlooked. We hypothesized that incorporating TE signatures would increase the resolution of B-cell identity during healthy and malignant conditions. Here, we present the first comprehensive, locus-specific characterization of TE expression in benign germinal center (GC) B-cells, diffuse large B-cell lymphoma (DLBCL), Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt lymphoma (BL), and follicular lymphoma (FL). Our findings demonstrate unique human endogenous retrovirus (HERV) signatures in the GC and lymphoma subtypes whose activity can be used in combination with gene expression to define B-cell lineage in lymphoid malignancies, highlighting the potential of retrotranscriptomic analyses as a tool in lymphoma classification, diagnosis, and the identification of novel treatment groups.
Identifiants
pubmed: 37333202
doi: 10.1101/2023.06.08.544208
pmc: PMC10274920
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA260691
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States
Déclaration de conflit d'intérêts
Declaration of Interests Peter Martin: ADCT: Consultancy. All other authors declare no competing interests.